Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

ClinicalTrials.gov ID: NCT07284875

Public ClinicalTrials.gov record NCT07284875. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 21, 2026, 8:49 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The primary objective of the study is to determine the effects of ribupatide (KAI-9531) subcutaneous (SC) injection once weekly compared to placebo on percent change in body weight.

Study identification

NCT ID
NCT07284875
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kailera
Industry
Enrollment
2,340 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 17, 2025
Primary completion
Jan 31, 2028
Completion
Feb 29, 2028
Last update posted
Sep 2, 2026

2025 – 2028

United States locations

U.S. sites
24
U.S. states
18
U.S. cities
24
Facility City State ZIP Site status
Kailera Clinical Site Anniston Alabama 36207 Recruiting
Kailera Clinical Site Birmingham Alabama 35294 Recruiting
Kailera Clinical Site Cullman Alabama 35055 Recruiting
Kailera Clinical Site Sun City Arizona 85351 Recruiting
Kailera Clinical Site Escondido California 92025 Recruiting
Kailera Clinical Site Toluca Lake California 91602 Recruiting
Kailera Clinical Site Aurora Colorado 80012 Recruiting
Kailera Clinical Site Bridgeport Connecticut 06606 Recruiting
Kailera Clinical Site Jupiter Florida 33458 Recruiting
Kailera Clinical Site Lilburn Georgia 30047 Recruiting
Kailera Clinical Site Springfield Illinois 62072 Recruiting
Kailera Clinical Site Columbia Maryland 21045 Recruiting
Kailera Clinical Site Las Vegas Nevada 89119 Recruiting
Kailera Clinical Site Rochester New York 14609 Recruiting
Kailera Clinical Site Morehead City North Carolina 28557 Recruiting
Kailera Clinical Site Chickasha Oklahoma 73018 Recruiting
Kailera Clinical Site Mauldin South Carolina 29662 Recruiting
Kailera Clinical Site Chattanooga Tennessee 37405 Recruiting
Kailera Clinical Site Amarillo Texas 79124 Recruiting
Kailera Clinical Site Bellaire Texas 77401 Recruiting
Kailera Clinical Site DeSoto Texas 75115 Recruiting
Kailera Clinical Site Tomball Texas 77375 Recruiting
Kailera Clinical Site Salt Lake City Utah 84124 Recruiting
Kailera Clinical Site Danville Virginia 24541 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 80 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07284875, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 2, 2026 · Synced Sep 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07284875 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →